A Combination Study of CAR-T Therapy in r/r B-NHL

Clinical trial NCT05871684 · UNKNOWN

Trial details

NCT number: NCT05871684
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2023-06-10
Primary completion: 2024-05-20
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.